ロード中...
Adoptive immunotherapy against ovarian cancer
The standard front-line therapy for epithelial ovarian cancer (EOC) is combination of debulking surgery and platinum-based chemotherapy. Nevertheless, the majority of patients experience disease recurrence. Although extensive efforts to find new therapeutic options, cancer cells invariably develop d...
保存先:
| 出版年: | J Ovarian Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869278/ https://ncbi.nlm.nih.gov/pubmed/27188274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-016-0236-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|